Pioneer Homoeo Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.70 M
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.29 Cr
- Revenue Growth 3.21%
- Profit Growth -26.19%
- Ebitda -1.11%
- Net Worth 2.68%
- Total Assets 18.07%
About Pioneer Homoeo Pharma
Pioneer Homoeo Pharma Private Limited (PHPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 August 2009 and has a history of 15 years and six months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.70 M.
The company currently has active open charges totaling ₹1.29 Cr.
Rajesh Deo and Tudimilla Chaitanya serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24234TG2009PTC064802
- Company No.
064802
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Pioneer Homoeo Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Deo  | Director | 20-Aug-2009 | Current |
| Tudimilla Chaitanya | Director | 20-Aug-2009 | Current |
Financial Performance of Pioneer Homoeo Pharma.
Pioneer Homoeo Pharma Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 3.21% increase. The company also saw a substantial fall in profitability, with a 26.19% decrease in profit. The company's net worth moved up by a moderate rise of 2.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pioneer Homoeo Pharma?
In 2021, Pioneer Homoeo Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹12.90 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.74 Cr
- Central Bank Of India : 0.55 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2017 | Others | ₹7.40 M | Open |
| 19 May 2011 | Central Bank Of India | ₹5.50 M | Open |
How Many Employees Work at Pioneer Homoeo Pharma?
Pioneer Homoeo Pharma has a workforce of 11 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pioneer Homoeo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pioneer Homoeo Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.